Press Releases Archives - Page 16 of 103 - Lupin

BSE 2328.10 NSE 2324.50

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2328.10 NSE 2324.50

Lupin Receives Approval from U.S. FDA for Aripiprazole Tablets, USP

Lupin Appoints Christoph Funke as Chief Technical Operations Officer

Lupin Receives Approval from U.S. FDA for Doxycycline for Injection USP

Lupin and Birmingham City University Honour Graduates of Master’s Programme in Advancing Diabetes Care

Lupin Appoints Rakesh Bhardwaj as Chief Information Officer

Lupin Enters the S&P Global Sustainability Yearbook 2024

February 23, 2024

Lupin Receives Approval from U.S. FDA for Minzoya (Levonorgestrel and Ethinyl Estradiol Tablets, USP and Ferrous Bisglycinate Tablets)

February 16, 2024

EffRx Pharmaceuticals Signs Exclusive Licensing and Distribution Agreement with Lupin for Commercialization of BINOSTO® in Vietnam & Philippines

February 16, 2024

Lupin Launches Ganirelix Acetate Injection in the United States

February 15, 2024

Lupin Launches Bromfenac Ophthalmic Solution, 0.075% in the United States

February 13, 2024

1 2 … 15 16 17 … 102 103

Search

Hit enter to search or ESC to close